Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China flag China · Delayed Price · Currency is CNY
5.25
-0.19 (-3.49%)
Sep 10, 2026, 12:44 PM CST

SHE:300039 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
258.36278.58375.58327.87190.8140.11
Depreciation & Amortization
34.9633.4936.0537.5331.7133.86
Other Amortization
1.532.190.290.110.01-
Loss (Gain) From Sale of Assets
0.2-0.040.260.210.170.22
Asset Writedown & Restructuring Costs
12.678.82-3.037.330.65-6.16
Loss (Gain) From Sale of Investments
-20.64-18.86-11.43-4.9210.694.85
Other Operating Activities
0.21-0.31-0.43-1.64-0.44-0.68
Change in Accounts Receivable
1.2923.4-0.1499.5358.32-74.9
Change in Inventory
-12.91-12.73-16.26-10.334.0627.22
Change in Accounts Payable
-92.61-84.92-102.8-60.1876.9-4.37
Change in Other Net Operating Assets
-3.45-1.62-4.32-5.336.83.33
Operating Cash Flow
179.72230.74278.95382.66376.42126.08
Operating Cash Flow Growth
-41.59%-17.28%-27.10%1.66%198.56%-49.70%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-18.03-27.04-140.52-29.08-31.62-42.55
Sale of Property, Plant & Equipment
0.270.510.030.030.270.15
Cash Acquisitions
------14.52
Investment in Securities
90.09227.8790.73-181.21-257.11-29.93
Other Investing Activities
53.0490.216.3311.633.083.34
Investing Cash Flow
125.37291.54-33.43-198.63-285.37-83.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-1.325.42---
Total Debt Issued
1.321.325.42---
Short-Term Debt Repaid
--0.24----
Long-Term Debt Repaid
------37.72
Total Debt Repaid
-0.19-0.24----37.72
Net Debt Issued (Repaid)
1.131.095.42---37.72
Common Dividends Paid
-136.03-136.03-104.6-62.76-52.3-31.64
Other Financing Activities
---0.05---
Financing Cash Flow
-134.9-134.95-99.23-62.76-52.3-69.37

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
170.2387.34146.3121.2738.75-26.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
161.7203.7138.43353.59344.883.53
Free Cash Flow Growth
-44.35%47.16%-60.85%2.55%312.79%-64.71%
Free Cash Flow Margin
16.00%17.67%9.40%22.18%30.82%7.59%
Free Cash Flow Per Share
0.150.200.130.340.330.08
Levered Free Cash Flow
-77.19180.9415.48261.78275.0416.78
Unlevered Free Cash Flow
-77.1618115.5261.78275.0416.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
--0.04---
Cash Income Tax Paid
164.95192.56239.25255.43144.47157.16
Change in Working Capital
-107.57-73.14-118.3316.17142.82-46.13